BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 29034612)

  • 1. Variability index of tacrolimus serum levels in pediatric liver transplant recipients younger than 12 years: Non-adherence or risk of non-adherence?
    de Oliveira JTP; Kieling CO; da Silva AB; Stefani J; Witkowski MC; Smidt CR; Mariano da Rocha CR; Hirakata VN; Grossini MDG; Zanotelli ML; Gonçalves Vieira SM
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 29034612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association Between Neighborhood-level Socioeconomic Deprivation and the Medication Level Variability Index for Children Following Liver Transplantation.
    Wadhwani SI; Bucuvalas JC; Brokamp C; Anand R; Gupta A; Taylor S; Shemesh E; Beck AF
    Transplantation; 2020 Nov; 104(11):2346-2353. PubMed ID: 32032293
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Medication level variability index predicts rejection, possibly due to nonadherence, in adult liver transplant recipients.
    Christina S; Annunziato RA; Schiano TD; Anand R; Vaidya S; Chuang K; Zack Y; Florman S; Shneider BL; Shemesh E
    Liver Transpl; 2014 Oct; 20(10):1168-77. PubMed ID: 24931127
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Medication Level Variability Index (MLVI) Predicts Poor Liver Transplant Outcomes: A Prospective Multi-Site Study.
    Shemesh E; Bucuvalas JC; Anand R; Mazariegos GV; Alonso EM; Venick RS; Reyes-Mugica M; Annunziato RA; Shneider BL
    Am J Transplant; 2017 Oct; 17(10):2668-2678. PubMed ID: 28321975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Medication Level Variability Index (MLVI) as a potential predictive biomarker of graft-versus-host disease in pediatric hematopoietic stem cell transplant patients.
    Skeens MA; Dietrich MS; Ryan-Wenger N; Gilmer MJ; Mulvaney SA; Akard TF
    Pediatr Transplant; 2019 Aug; 23(5):e13451. PubMed ID: 31066981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An objective measure to identify pediatric liver transplant recipients at risk for late allograft rejection related to non-adherence.
    Venkat VL; Nick TG; Wang Y; Bucuvalas JC
    Pediatr Transplant; 2008 Feb; 12(1):67-72. PubMed ID: 18186891
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Non-adherence and graft failure in adult liver transplant recipients.
    Lieber SR; Volk ML
    Dig Dis Sci; 2013 Mar; 58(3):824-34. PubMed ID: 23053889
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance of modified-release tacrolimus after conversion in liver transplant patients indicates potentially favorable outcomes in selected cohorts.
    Considine A; Tredger JM; Heneghan M; Agarwal K; Samyn M; Heaton ND; O'Grady JG; Aluvihare VR
    Liver Transpl; 2015 Jan; 21(1):29-37. PubMed ID: 25312292
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Medication adherence and rejection rates in older vs younger adult liver transplant recipients.
    Leven EA; Annunziato R; Helcer J; Lieber SR; Knight CS; Wlodarkiewicz C; Soriano RP; Florman SS; Schiano TD; Shemesh E
    Clin Transplant; 2017 Jun; 31(6):. PubMed ID: 28370346
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of once-daily LCP-Tacrolimus with adolescent and young adult solid organ transplant recipients.
    Householder S; Ramakrishnan A; Chen JK; Gorsch L; Tsapepas D; Lobritto S; Rundle A; Vittorio JM
    Pediatr Transplant; 2024 Jun; 28(4):e14777. PubMed ID: 38702932
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Medication adherence in pediatric and adolescent liver transplant recipients.
    Shemesh E; Shneider BL; Savitzky JK; Arnott L; Gondolesi GE; Krieger NR; Kerkar N; Magid MS; Stuber ML; Schmeidler J; Yehuda R; Emre S
    Pediatrics; 2004 Apr; 113(4):825-32. PubMed ID: 15060234
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impact of psychosocial factors on medication level variability index and outcomes in pediatric liver transplant recipients.
    Sakhuja S; Himes R; Carreker C; Guffey D; Beer S; Amin M; Hiremath G; Mysore K
    Pediatr Transplant; 2023 Feb; 27(1):e14425. PubMed ID: 36325588
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Variability in tacrolimus blood levels increases the risk of late rejection and graft loss after solid organ transplantation in older children.
    Pollock-Barziv SM; Finkelstein Y; Manlhiot C; Dipchand AI; Hebert D; Ng VL; Solomon M; McCrindle BW; Grant D
    Pediatr Transplant; 2010 Dec; 14(8):968-75. PubMed ID: 21040278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adequate exposure to tacrolimus with sublingual administration in pediatric liver transplant patients.
    Riva N; Galván ME; Cáceres-Guido P; Dip M; Licciardone N; Imventarza O; Schaiquevich P; Buamscha D
    Int J Clin Pharmacol Ther; 2017 Apr; 55(4):352-354. PubMed ID: 28079516
    [No Abstract]   [Full Text] [Related]  

  • 15. Improved adherence and outcomes for pediatric liver transplant recipients by using text messaging.
    Miloh T; Annunziato R; Arnon R; Warshaw J; Parkar S; Suchy FJ; Iyer K; Kerkar N
    Pediatrics; 2009 Nov; 124(5):e844-50. PubMed ID: 19822583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-Management Measurement and Prediction of Clinical Outcomes in Pediatric Transplant.
    Annunziato RA; Bucuvalas JC; Yin W; Arnand R; Alonso EM; Mazariegos GV; Venick RS; Stuber ML; Shneider BL; Shemesh E
    J Pediatr; 2018 Feb; 193():128-133.e2. PubMed ID: 29162346
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pharmacoepidemiology of tacrolimus in pediatric liver transplantation.
    Riva N; Schaiquevich P; Cáceres Guido P; Halac E; Dip M; Imventarza O
    Pediatr Transplant; 2017 Aug; 21(5):. PubMed ID: 28574195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Relation between mRNA expression level of multidrug resistance 1/ABCB1 in blood cells and required level of tacrolimus in pediatric living-donor liver transplantation.
    Goto M; Masuda S; Kiuchi T; Ogura Y; Oike F; Tanaka K; Uemoto S; Inui K
    J Pharmacol Exp Ther; 2008 May; 325(2):610-6. PubMed ID: 18252812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recruiting a representative sample in adherence research-The MALT multisite prospective cohort study experience.
    Shemesh E; Mitchell J; Neighbors K; Feist S; Hawkins A; Brown A; Wanrong Y; Anand R; Stuber ML; Annunziato RA
    Pediatr Transplant; 2017 Dec; 21(8):. PubMed ID: 28984072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mapping children by ALT 4-5 years after liver transplant: Potential individual and population applications.
    Dixon W; Perito ER; Bucuvalas J; Feng S
    Pediatr Transplant; 2023 Sep; 27(6):e14569. PubMed ID: 37458328
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.